ARCHIVES

DCE Advisors Okay Study Of Cancer Risk in Breast Augmentation

This article is from The Cancer Letter archive.

Vol. 17 No. 45 | November 22, 1991

Download PDF Visit The Full Archive

Related Articles

Revlimid Also Demonstrates Response in Mantle Cell

July 29, 2011

Prevention Task Force Unable To Reach Consensus On New Division, Tries To Avoid More Disruption

July 6, 1979

In Brief: National Patient Advocates Foundation Formed To Seek Health Insurance Reform

November 15, 1996

Afinitor Delayed Progression Compared To Tamoxifen Alone In Randomized Phase II Study

December 31, 2010

Bush Appoints Niederhuber Chairman of NCAB

August 2, 2002

In Brief: New Clinical Oncology RFP Ready Soon; CCIRC, Joftes Agree On Funding Method For Symposia

March 9, 1979